Table 2:

Bivariable Analysis Gender

Variable	Total (n=92)	Female (n=74)	Male (n=18)	P-value
Age at Seizure Onset (weeks) Median (IQR)	5.0 (3.0,8.0)	5.0 (3.0,8.0)	6.0 (4.0,9.0)	0.35
Age at Last Visit (years) Median (IQR)	5.0 (2.0,11.0)	5.0 (2.0,10.0)	4.8 (2.5,12.0)	0.73
Seizure Type (Initial) (%)
Epileptic Spasms	21 (23)	14 (19)	7 (39)	0.11
Tonic	29 (32)	25 (34)	4 (22)	0.34
HTSS	9 (10)	8 (11)	1 (6)	0.50
GTC	20 (22)	18 (24)	2 (11)	0.34
Myoclonic	6 (7)	4 (5)	2 (11)	0.33
Clonic	8 (9)	7 (9)	1 (6)	0.60
Focality	20 (22)	17 (23)	3 (17)	0.75
Hypsarrhythmia (%)*	35 (38)	25 (34)	10 (56)	0.11
Seizure Types (Anytime) (%)
Epileptic Spasms	75 (82)	61 (82)	14 (78)	0.74
Tonic	59 (64)	48 (65)	11 (61)	0.77
HTSS Combined	52 (57)	43 (58)	9 (50)	0.53
HTSS	22 (24)	19 (26)	3 (17)	0.55
HTSS like	31 (34)	24 (32)	7 (39)	0.60
Generalized Tonic Clonic	31 (34)	29 (39)	2 (11)	0.03
Myoclonic	36 (39)	30 (41)	6 (33)	0.57
Clonic	10 (11)	7 (9)	3 (17)	0.40
Atonic	8 (9)	8 (11)	0 (0)	0.35
Absence	2 (2)	2 (3)	0 (0)	0.48
Focality	28 (30)	22 (30)	6 (33)	0.77
Period of Seizure Freedom (%)
1–3 months	8 (9)	5 (7)	3 (17)	0.19
3–6 months	11 (12)	8 (11)	3 (17)	0.44
6–12 months	10 (11)	8(11)	2 (11)	0.97
> 12 months	11 (12)	10 (14)	1 (6)	0.35
Combined Seizure Freedom	40 (43)	31 (42)	9 (50)	0.53
Cortical Visual Impairment (%)	70 (76)	57 (77)	13 (72)	0.67
CDS - Mean (std)	2.6 (2.1)	2.6 (2.0)	2.5 (2.4)	0.81

Table compares the same traits as table one with the same definitions but by gender (P-values are unadjusted).